Table 6.
s25D in relation to prevalence of comorbid conditions in bariatric-surgery subjects
| Comorbidity | n (%) | S25D (ng/ml) ± sd | P value |
|---|---|---|---|
| Diabetes | 0.55 | ||
| Present | 13/48 (27) | 14.9 ± 9.0 | |
| Absent | 35/48 (73) | 16.5 ± 8.3 | |
| Insulin resistancea | 0.07 | ||
| Present | 25/45 (56) | 14.0 ± 7.7 | |
| Absent | 20/45 (44) | 18.4 ± 8.8 | |
| Hypertension | 0.87 | ||
| Present | 27/48 (56) | 15.9 ± 8.2 | |
| Absent | 21/48 (44) | 16.3 ± 8.9 | |
| Hypercholesterolemia | 0.37 | ||
| Present | 15/48 (31) | 17.8 ± 9.5 | |
| Absent | 33/48 (69) | 15.3 ± 7.9 | |
| Osteoarthritis | 0.03 | ||
| Present | 19/48 (40) | 12.9 ± 4.2 | |
| Absent | 29/48 (60) | 18.2 ± 19.7 | |
| Sleep apnea | 0.44 | ||
| Present | 19/48 (40) | 14.9 ± 5.6 | |
| Absent | 29/48 (60) | 16.9 ± 9.6 | |
| GERD | 0.52 | ||
| Present | 26/48 (54) | 16.8 ± 6.5 | |
| Absent | 22/48 (46) | 15.3 ± 10.4 |
a
Insulin resistance measured by homeostasis model assessment higher than 5.